| Increasing Movement of Domestic Companies Towards Global Markets... Companies Supporting Global Business also Gaining Attention.
| Services Focusing on High Efficiency in Terms of Time and Cost, Including End-to-End Solutions for Market Entry.
| JNPMEDI Introduces a Virtual Data Room Optimized for Global Business in Drug Development and Clinical Trials.
| Companies like DreamCIS Provides Networking and Consulting for Pharmaceutical•Biotech Companies Entering Overseas Markets.
As the saying goes, "A big fish must swim in deep waters," South Korean pharmaceutical and biotech companies are actively aiming beyond the domestic market toward the global stage. These companies are venturing abroad, especially towards the United States, which boasts the largest pharmaceutical market, to seize more opportunities globally.
In this context, the role of companies aiding domestic biotechs in their global market expansion has become increasingly prominent. These companies offer robust support ranging from end-to-end solutions facilitating swift local market entry to tailored consulting services.
■ JNPMEDI's Virtual Data Room: A Solution for Global Business Optimization in Pharma & Biotech
The medical data platform company JNPMEDI is enhancing the stable global business operations of pharmaceutical and biotech companies through its virtual data room solution, "Maven VDR (Maven Virtual Data Room)."
Launched this month, Maven VDR is a new solution by JNPMEDI designed to securely manage confidential documents and internal data critical to key business processes in the pharmaceutical and biotech sectors, including new drug development and clinical trials. With Maven VDR, companies can securely manage and share various documents, information, and technical materials required in international business activities such as licensing in/out, technology exchange, and joint research.
Maven VDR's strong security features, including data integrity maintenance, excellent personal data protection, and real-time monitoring of document access and changes, make it an ideal solution for the sensitive information needs of the pharmaceutical and biotech market. This is particularly significant as the demand is expected to grow with the increasing number of Korean pharmaceutical and biotech companies seeking to attract global capital investment or pursue mergers and acquisitions.
JNPMEDI plans to offer on-demand services that respond to all stages of key business processes in the pharmaceutical and biotech field, leveraging insights gained from the Maven VDR solution and their consulting experience in clinical trials and new drug development.
Additionally, JNPMEDI has introduced the "FDA Expert Solution" to assist South Korean pharmaceutical and biotech companies in successfully entering the U.S. market. This comprehensive support includes preparing clinical and non-clinical data, documentation, clinical trial management, and regulatory strategy development, covering all aspects of communication with the FDA.
| Increasing Movement of Domestic Companies Towards Global Markets... Companies Supporting Global Business also Gaining Attention.
| Services Focusing on High Efficiency in Terms of Time and Cost, Including End-to-End Solutions for Market Entry.
| JNPMEDI Introduces a Virtual Data Room Optimized for Global Business in Drug Development and Clinical Trials.
| Companies like DreamCIS Provides Networking and Consulting for Pharmaceutical•Biotech Companies Entering Overseas Markets.
As the saying goes, "A big fish must swim in deep waters," South Korean pharmaceutical and biotech companies are actively aiming beyond the domestic market toward the global stage. These companies are venturing abroad, especially towards the United States, which boasts the largest pharmaceutical market, to seize more opportunities globally.
In this context, the role of companies aiding domestic biotechs in their global market expansion has become increasingly prominent. These companies offer robust support ranging from end-to-end solutions facilitating swift local market entry to tailored consulting services.
■ JNPMEDI's Virtual Data Room: A Solution for Global Business Optimization in Pharma & Biotech
The medical data platform company JNPMEDI is enhancing the stable global business operations of pharmaceutical and biotech companies through its virtual data room solution, "Maven VDR (Maven Virtual Data Room)."
Launched this month, Maven VDR is a new solution by JNPMEDI designed to securely manage confidential documents and internal data critical to key business processes in the pharmaceutical and biotech sectors, including new drug development and clinical trials. With Maven VDR, companies can securely manage and share various documents, information, and technical materials required in international business activities such as licensing in/out, technology exchange, and joint research.
Maven VDR's strong security features, including data integrity maintenance, excellent personal data protection, and real-time monitoring of document access and changes, make it an ideal solution for the sensitive information needs of the pharmaceutical and biotech market. This is particularly significant as the demand is expected to grow with the increasing number of Korean pharmaceutical and biotech companies seeking to attract global capital investment or pursue mergers and acquisitions.
JNPMEDI plans to offer on-demand services that respond to all stages of key business processes in the pharmaceutical and biotech field, leveraging insights gained from the Maven VDR solution and their consulting experience in clinical trials and new drug development.
Additionally, JNPMEDI has introduced the "FDA Expert Solution" to assist South Korean pharmaceutical and biotech companies in successfully entering the U.S. market. This comprehensive support includes preparing clinical and non-clinical data, documentation, clinical trial management, and regulatory strategy development, covering all aspects of communication with the FDA.